EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, MindWalk Holdings's Enterprise Value is €52.13 Mil.
MindWalk Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Jan. 2026 was €-7.43 Mil. Therefore, MindWalk Holdings's EV-to-FCF for today is -7.01.
The historical rank and industry rank for MindWalk Holdings's EV-to-FCF or its related term are showing as below:
FRA:TQB0'
s EV-to-FCF Range Over the Past 10 Years
Min: -968.41 Med: -10.18 Max: 1958.17
Current: -6.87
During the past 13 years, the highest EV-to-FCF of MindWalk Holdings was 1958.17. The lowest was -968.41. And the median was -10.18.
FRA:TQB0's EV-to-FCF is ranked worse than 100% of 329
companies
in the Biotechnology industry
Industry Median: 15.85
vs FRA:TQB0: -6.87
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
MindWalk Holdings's PE Ratio (TTM) for today is calculated as:
MindWalk Holdings's share price for today is €1.20.
MindWalk Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.111.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
MindWalk Holdings EV-to-FCF Related Terms
MindWalk Holdings EV-to-FCF Historical Data
* Premium members only.
The historical data trend for MindWalk Holdings's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:TQB0 vs ANVS, GANX, EXOZ: EV-to-FCF Comparison
For the Biotechnology subindustry, MindWalk Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MindWalk Holdings EV-to-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, MindWalk Holdings's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where MindWalk Holdings's EV-to-FCF falls into.
MindWalk Holdings's current Enterprise Value is €52.13 Mil.
MindWalk Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-7.43 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MindWalk Holdings (FRA:TQB0) has a EV-to-FCF of -7.01 as of Jul. 12, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on MindWalk Holdings and its competitors. According to the industry distribution chart, MindWalk Holdings ranks #999999 out of 329 companies in the Biotechnology industry.
Is MindWalk Holdings' EV-to-FCF too high?
MindWalk Holdings' current EV-to-FCF is -7.01. Based on the distribution chart, MindWalk Holdings ranks #999999 out of 329 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, MindWalk Holdings has a GF Score™ of 23/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MindWalk Holdings' EV-to-FCF compare to ANVS and GANX?
According to the Biotechnology industry distribution chart, MindWalk Holdings ranks #999999 out of 329 companies for EV-to-FCF. This places MindWalk Holdings in the lower half of its industry. The industry median EV-to-FCF is 15.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 15.85, based on 329 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on MindWalk Holdings and its competitors. For the Biotechnology industry, the median EV-to-FCF is 15.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MindWalk Holdings's current EV-to-FCF is -7.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MindWalk Holdings stock overvalued right now?
Based on GuruFocus' analysis, MindWalk Holdings (FRA:TQB0) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.53, compared to a current price of €1.20 — trading 126.4% above its estimated fair value. The current EV-to-FCF is -7.01. MindWalk Holdings' overall GF Score™ is 23/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For MindWalk Holdings (FRA:TQB0), the current EV-to-FCF is -7.01 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MindWalk Holdings (FRA:TQB0) Overvalued in 2026?
Based on GuruFocus' analysis, MindWalk Holdings stock appears to be overvalued.
The current stock price of €1.20 is trading 126.4% above its estimated GF Value™ of €0.53.
GuruFocus considers MindWalk Holdings to be Significantly Overvalued.
Key valuation signals for FRA:TQB0:
EV-to-FCF: -7.01
GF Value™: €0.53 vs. price of €1.20 (126.4% above fair value)
No single metric tells the full story. See the FRA:TQB0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
23GF Score
Get the complete analysis for FRA:TQB0
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:TQB0 has been successfully added to your 
